NSAIDs and Alzheimer's disease: Contribution of observational epidemiologic studies

Neurobiology of Aging

Volumn 19, Issue 6, 1998, Pages 617-618

  Launer, L J ^a   In'T Veld, B A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN E; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; DRUG USE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0032467509     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00103-1     Document Type: Article

References (7)

1. C Cornelius L Fratiglioni J Fastbom Z Guo M Viitanen B Winblad No support for a protective effect of NSAIDs against Alzheimer’s disease from a follow-up population-based study Neurobiol. Aging 19 Suppl 4 1998 S28
2. P Eikelenboom S.-S Zhan W.A van Gool D Allsop Inflammatory mechanisms in Alzheimer’s disease Trends Pharmacol. Sci. 15 1994 447 450
3. A Hofman A Ott M.M Breteler M.L Bots A.J Slooter F van Harskamp C.N van Duijn C van Broeckhoven D.E Grobbee Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study Lancet 349 1998 151 154
4. L.I Launer A.W Hoes Nonsteroidal antiinflammatory drug use and the risk for Alzheimer’s disease Weighing the epidemiologic evidence Neurogerontol. Neurogeriatrics 2 1998 133 140
5. A.J Slooter C.M van Duijn Genetic epidemiology of Alzheimer’s disease Epidemiol. Rev. 19 1997 107 119
6. W.F Stewart C Kawas M Corrada F.J Metter Risk of Alzheimer’s disease and duration of NSAID use Neurology 48 1997 626 632
7. S.L West B.L Strom B Freundlich E Normand G Koch D.A Savitz Completeness of prescription recording in outpatient medical records from a health maintenance organization J. Clin. Epidemiol. 47 1994 165 171